Analog Devices (ADI) CEO trades 10,000 shares under 10b5-1 plan
Rhea-AI Filing Summary
Analog Devices Chair & CEO Vincent Roche exercised 10,000 non-qualified stock options at $108.08 per share, receiving the same number of common shares, then sold 10,000 common shares at $363.00 on August 3, 2026 pursuant to a Rule 10b5-1 plan adopted on December 3, 2025. After the option exercise, he directly holds 70,803 stock options and indirectly holds 23,515 and 50,000 common shares through the Vincent Roche 2024 and 2026 Grantor Retained Annuity Trusts.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 10,000 shares ($2.55M approx. pre-tax spread)
Exercise and Sale
5 txns
Insider
ROCHE VINCENT
Role
Chair & CEO
Sold
10,000 shs ($3.63M)
Approx. gross sale proceeds
$3.63M
Approx. exercise cost
$1.08M
Approx. pre-tax spread
$2.55M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) F4 | 10,000 | $108.08 | $1.08M |
| Exercise | Comm Stock - $.16-2/3 value | 10,000 | $108.08 | $1.08M |
| Sale | Comm Stock - $.16-2/3 value F1 | 10,000 | $363.00 | $3.63M |
| holding | Comm Stock-$.16-2/3 value F2 | -- | -- | -- |
| holding | Comm Stock-$.16-2/3 value F3 | -- | -- | -- |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 70,803 shares (Direct);
Comm Stock - $.16-2/3 value — 137,537.875 shares (Direct);
Comm Stock-$.16-2/3 value — 23,515 shares (Indirect, Vincent Roche 2024 Grantor Retained Annuity Trust);
Comm Stock-$.16-2/3 value — 50,000 shares (Indirect, Vincent Roche 2026 Grantor Retained Annuity Trust)
Footnotes (4)
- F1. These shares were sold pursuant to a 10b5-1 plan adopted by the reporting person on December 3, 2025.
- F2. Shares held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024.
- F3. Shares held by the Vincent Roche 2026 Grantor Retained Annuity Trust dated January 11, 2026.
- F4. This option is fully vested.
Key Figures
Options exercised: 10,000 shares
Option exercise price: $108.08 per share
Shares sold: 10,000 shares
+4 more
7 metrics
Options exercised
10,000 shares
Non-Qualified Stock Option exercised on August 3, 2026
Option exercise price
$108.08 per share
Exercise price of Non-Qualified Stock Option
Shares sold
10,000 shares
Common stock sale on August 3, 2026
Sale price
$363.00 per share
Price for 10,000 common shares sold
Options held after transaction
70,803 options
Total non-qualified stock options directly held after exercise
2024 GRAT indirect holding
23,515 shares
Shares held by the Vincent Roche 2024 Grantor Retained Annuity Trust
2026 GRAT indirect holding
50,000 shares
Shares held by the Vincent Roche 2026 Grantor Retained Annuity Trust
Key Terms
Rule 10b5-1 plan, Non-Qualified Stock Option, Grantor Retained Annuity Trust, Comm Stock - $.16-2/3 value
4 terms
Rule 10b5-1 plan financial
"These shares were sold pursuant to a Rule 10b5-1 plan adopted by the reporting person"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
Non-Qualified Stock Option financial
"Security title reported as Non-Qualified Stock Option (right to buy) for 10,000 shares"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Grantor Retained Annuity Trust financial
"Shares held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
Comm Stock - $.16-2/3 value financial
"Underlying security title listed as Comm Stock - $.16-2/3 value for exercised options"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What transactions did Analog Devices (ADI) CEO Vincent Roche report in this Form 4?
Vincent Roche exercised 10,000 stock options at $108.08 per share, acquired 10,000 common shares, then sold 10,000 Analog Devices shares at $363.00 on August 3, 2026, all recorded in this Form 4 filing.
How many Analog Devices (ADI) options does Vincent Roche hold after the reported transactions?
Following the August 3, 2026 option exercise, Vincent Roche is reported as directly holding 70,803 non-qualified stock options, with the exercised option grant shown as fully vested and expiring on March 13, 2029.